Literature DB >> 6925980

Antigens in immune complexes from patients with breast cancer. Identification of autoantigens in immune complexes isolated from breast cancer effusions.

Z Gilead, A Hatzubai, D Sulitzeanu.   

Abstract

Sera and effusion fluids of patients with breast cancer (BC) contain immune complexes (IC). Antigens present in these complexes were isolated as follows: a pool of effusions from patients with BC was fractionated with ammonium sulfate. The proteins precipitating at 40% saturation were further fractionated by filtration through a Sephadex G-200 column. The material recovered in the first peak (molecules larger than monomeric IgG) was brought to pH 3.0 to dissociate the IC, and the mixture was filtered through a column of Sephacryl S-300 at pH 3.0. Proteins smaller than monomeric IgG were collected, radioiodinated, and used as antigens (125Ag) to search for corresponding antibodies in sera of patients with BC (BCS) and of healthy individuals (NHS). 125Ag was reacted with the sera and the immune complexes obtained were precipitated with an antiserum to human Ig and analyzed by SDS-polyacrylamide gel electrophoresis followed by autoradiography. Both NHS and BCS contained antibodies against two antigens; one of these appeared as a strong band of 17KD, the other as a doublet of approximately 25KD. It is concluded that some of the proteins in the IC from patients with BC are auto-antigens. No BC-specific antigens were identified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6925980     DOI: 10.1007/bf00205380

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  17 in total

Review 1.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Characterization of immune complexes from the pleural effusion of a breast cancer patient.

Authors:  L D Papsidero; S R Harvey; M C Snyderman; T Nemoto; L Valenzuela; T M Chu
Journal:  Int J Cancer       Date:  1978-06-15       Impact factor: 7.396

3.  A technique for the purification of immune complexes using rheumatoid factor.

Authors:  Z Gilead; D Sulitzeanu
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  Protein-methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy.

Authors:  M da Costa; W Isacoff; S P Rothenberg; M P Iqbal
Journal:  Cancer       Date:  1980-08-01       Impact factor: 6.860

5.  Detection of alkaline phosphatase/immunoglobulin complexes.

Authors:  J E Buttery; C R Milner; P Nenadovic; P R Pannall
Journal:  Clin Chem       Date:  1980-10       Impact factor: 8.327

6.  Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer.

Authors:  R B Herberman; M Bordes; P H Lambert; H S Luthra; R A Robins; P Sizaret; A Theofilopoulos
Journal:  Int J Cancer       Date:  1981-05-15       Impact factor: 7.396

7.  Cell membrane antigen isolation with the staphylococcal protein A-antibody adsorbent.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  Fixation of human anti-actin autoantibodies on skeletal muscle fibres.

Authors:  C Chaponnier; L Kohler; G Gabbiani
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

9.  Antigen--antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia--hand mirror variant (ALL-HMC).

Authors:  S A Stass; T M Phillips; O S Weislow; E Perlin; H R Schumacher
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

10.  ACTH-like activity in immune complexes of patients with oat-cell carcinoma of the lung.

Authors:  K Havemann; C Gropp; A Scheuer; T Scherfe; M Gramse
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

View more
  1 in total

1.  Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.

Authors:  Z Ronai; J Shaham; J Stein; D Sulitzeanu
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.